estriol has been researched along with Autoimmune Disease in 4 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the use of estriol in the treatment of experimental autoimmune encephalomyelitis (EAE) and other cell mediated autoimmune diseases." | 7.70 | Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. ( Dalal, MA; Kim, S; Liva, SM; Verity, MA; Voskuhl, RR, 1999) |
| "Estriol treated mice also exhibited a rapid elevation in serum IL-6 levels following LPS challenge with the peak increase occurring 1 hr post LPS." | 5.29 | Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia. ( Ahmari, SE; Bryan-Poole, N; Evans, GF; Glasebrook, AL; Short, L; Zuckerman, SH, 1996) |
| " Estriol (E3), a pregnancy-specific estrogen, has therapeutic efficacy in MS and EAE, and we evaluated whether E3 could act exclusively through DCs to protect against the inflammatory autoimmune disease EAE." | 3.77 | Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. ( Bedarf, A; Gienapp, IE; McClain, MA; Papenfuss, TL; Powell, ND; Shawler, T; Singh, A; Whitacre, CC, 2011) |
| "To evaluate the use of estriol in the treatment of experimental autoimmune encephalomyelitis (EAE) and other cell mediated autoimmune diseases." | 3.70 | Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. ( Dalal, MA; Kim, S; Liva, SM; Verity, MA; Voskuhl, RR, 1999) |
| "Estriol treated mice also exhibited a rapid elevation in serum IL-6 levels following LPS challenge with the peak increase occurring 1 hr post LPS." | 1.29 | Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia. ( Ahmari, SE; Bryan-Poole, N; Evans, GF; Glasebrook, AL; Short, L; Zuckerman, SH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papenfuss, TL | 1 |
| Powell, ND | 1 |
| McClain, MA | 1 |
| Bedarf, A | 1 |
| Singh, A | 1 |
| Gienapp, IE | 1 |
| Shawler, T | 1 |
| Whitacre, CC | 1 |
| Murase, JE | 1 |
| Wu, JJ | 1 |
| Weinstein, GD | 1 |
| Zuckerman, SH | 1 |
| Ahmari, SE | 1 |
| Bryan-Poole, N | 1 |
| Evans, GF | 1 |
| Short, L | 1 |
| Glasebrook, AL | 1 |
| Kim, S | 1 |
| Liva, SM | 1 |
| Dalal, MA | 1 |
| Verity, MA | 1 |
| Voskuhl, RR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Tolerability of Oral Two-Doses Estroprogestins Associated With Interferon-Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis[NCT00151801] | Phase 2 | 200 participants | Interventional | 2002-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for estriol and Autoimmune Disease
| Article | Year |
|---|---|
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Topics: Animals; Autoimmune Diseases; Biomarkers; Cell Differentiation; Cells, Cultured; Coculture Technique | 2011 |
Estrogen and the skin.
Topics: Autoimmune Diseases; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); F | 2006 |
Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia.
Topics: Animals; Autoimmune Diseases; Cells, Cultured; Endotoxemia; Estradiol; Estriol; Estrogen Antagonists | 1996 |
Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.
Topics: Animals; Autoimmune Diseases; Brain; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experime | 1999 |